FedEx uses Blockchain for distribution of anti-cancer drugs

The FedEx Institute of Technology announced its partnership with the pharmaceutical services company Good Shepherd Pharmacy to develop a Blockchain-based infrastructure to help cancer patients obtain medication.

This technological institute is an organization that works as a promoter of work and interdisciplinary research in emerging technologies that operates in conjunction with the research infrastructure of the University of Memphis since February of this year in order to strengthen the university and turn it into a research power and technology.

In this sense, Good Shepherd Pharmacy (also located in Memphis) recognizes the Blockchain as a means to carry unused medications for cancer patients and to make them available to economically disadvantaged patients who could not obtain them otherwise, developing a safe and confidential way. to distribute medical information.

The Good Shepherd pharmacy, based in Memphis, reportedly recognized the Blockchain as a means to recover unused medications from cancer patients and transmit them to economically disadvantaged patients who could not pay them regularly.

A secure and immutable ledger would allow a secure and confidential distribution of medical information. The Executive Director of the Good Shepherd Pharmacy, Phil Baker, said:

"Nothing more in Tennessee, more than 10 million dollars in perfectly functional drugs go down the toilet year after year. Blockchain is the solution to this problem, so the REMEDI Project (REclaiming MEDicine) will take these medications to patients who could not otherwise use them. "

The Institute will hold an event to attract Blockchain enthusiasts and enthusiasts to discuss the initiative proposed by Good Shepherd. The event will be held in conjunction with Blockchain 901, a professional organization that seeks to grow the number of technology professionals in the Memphis area.

Last month, Microsoft and supply tracking solutions provider Adents announced another supply chain-based pharmaceutical project. Proposing a model that would offer traceability to both sides and visibility from the point of origin through the entire chain of command, which would allow users to track each article within the same case.